MicroRNA-150 contributes to ischemic stroke through its effect on cerebral cortical neuron survival and function by inhibiting ERK1/2 axis via Mal.
Animals
Apoptosis
Case-Control Studies
Cell Proliferation
Cells, Cultured
Cerebral Cortex
/ enzymology
Disease Models, Animal
Humans
Infarction, Middle Cerebral Artery
/ enzymology
MAP Kinase Signaling System
Male
MicroRNAs
/ genetics
Mitogen-Activated Protein Kinase 1
/ metabolism
Mitogen-Activated Protein Kinase 3
/ metabolism
Myelin and Lymphocyte-Associated Proteolipid Proteins
/ genetics
Neurons
/ enzymology
Rats, Sprague-Dawley
ERK1/2 axis
cerebral cortical neurons (CCNs)
ischemic stroke
mal
microRNA-150 (miR-150)
middle cerebral artery occlusion (MCAO)
Journal
Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
09
04
2018
accepted:
13
06
2018
pubmed:
26
8
2018
medline:
18
12
2019
entrez:
26
8
2018
Statut:
ppublish
Résumé
Ischemic stroke, caused by the blockage of blood supply, is a major cause of death worldwide. For identifying potential candidates, we explored the effects microRNA-150 (miR-150) has on ischemic stroke and its underlying mechanism by developing a stable middle cerebral artery occlusion (MCAO) rat model. Gene expression microarray analysis was performed to screen differentially expressed genes associated with MCAO. We evaluated the expression of miR-150 and Mal and the status of ERK1/2 axis in the brain tissues of MCAO rats. Then the cerebral cortical neurons (CCNs) were obtained and introduced with elevated or suppressed miR-150 or silenced Mal to validate regulatory mechanisms for miR-150 governing Mal in vitro. The relationship between miR-150 and Mal was verified by dual luciferase reporter gene assay. Besides, cell growth and apoptosis of CCNs were detected by means of MTT assay and flow cytometry analyses. We identified Mal as a downregulated gene in MCAO, based on the microarray data of GSE16561. MiR-150 was over-expressed and negatively targeted Mal in the brain tissues obtained from MCAO rats and their CCNs. Increasing miR-150 blocked the ERK1/2 axis, resulting in an inhibited cell growth of CNNs but an enhanced apoptosis. Furthermore, MiR-150 inhibition was observed to have effects on CNNs as opposed to those inhibited by miR-150 promotion. The key findings of this study support the notion that miR-150 under-expression-mediated direct promotion of Mal protects CNN functions through the activation of the ERK1/2 axis, and underscore the concept that miR-150 may represent a novel pharmacological target for ischemic stroke intervention.
Substances chimiques
MAL protein, human
0
MIRN150 microRNA, human
0
MIRN150 microRNA, rat
0
Mal protein, rat
0
MicroRNAs
0
Myelin and Lymphocyte-Associated Proteolipid Proteins
0
Mapk1 protein, rat
EC 2.7.11.24
Mitogen-Activated Protein Kinase 1
EC 2.7.11.24
Mitogen-Activated Protein Kinase 3
EC 2.7.11.24
Types de publication
Journal Article
Retracted Publication
Langues
eng
Sous-ensembles de citation
IM
Pagination
1477-1490Commentaires et corrections
Type : RetractionIn
Informations de copyright
© 2018 Wiley Periodicals, Inc.